Abstract
Acute erythroid leukemia (AEL) is a subtype of acute myeloid leukemia (AML) with features such as accumulation of maturation-arrested erythroblasts. Compared with AML, the progression of AEL is faster and the prognosis to available therapy is worse. However, its categorization is still being updated and the pathophysiology of AEL is still under research, making diagnosis and chemotherapy challenging for physicians. To achieve better outcomes, therapies should be optimized and new drugs should be developed. In this review, we summarize current strategies of diagnosis and therapies of AEL, and discuss prospective targets for chemotherapeutic agents based on the biological characteristics of AEL neoplastic cells as well as transcriptional factors and pathways related to erythroid differentiation.
Keywords: Acute erythroid leukemia, acute myeloid leukemia, chemotherapeutic agents, erythroid differentiation, GATA-1, GATA-2, Gfi1b, EKLF, EPO-related pathways.
Current Molecular Medicine
Title:Chemotherapeutics for Acute Erythroid Leukemia: Research, Present and Future
Volume: 21 Issue: 10
Author(s): Zexi Liao, Jiaxin Li, Jingjing Wu, Jing Liu*Shuming Sun*
Affiliation:
- Molecular Biology Research Center, School of Life Sciences, Central South University, Changsha, 410078,China
- Molecular Biology Research Center, School of Life Sciences, Central South University, Changsha, 410078,China
Keywords: Acute erythroid leukemia, acute myeloid leukemia, chemotherapeutic agents, erythroid differentiation, GATA-1, GATA-2, Gfi1b, EKLF, EPO-related pathways.
Abstract: Acute erythroid leukemia (AEL) is a subtype of acute myeloid leukemia (AML) with features such as accumulation of maturation-arrested erythroblasts. Compared with AML, the progression of AEL is faster and the prognosis to available therapy is worse. However, its categorization is still being updated and the pathophysiology of AEL is still under research, making diagnosis and chemotherapy challenging for physicians. To achieve better outcomes, therapies should be optimized and new drugs should be developed. In this review, we summarize current strategies of diagnosis and therapies of AEL, and discuss prospective targets for chemotherapeutic agents based on the biological characteristics of AEL neoplastic cells as well as transcriptional factors and pathways related to erythroid differentiation.
Export Options
About this article
Cite this article as:
Liao Zexi , Li Jiaxin , Wu Jingjing , Liu Jing *, Sun Shuming *, Chemotherapeutics for Acute Erythroid Leukemia: Research, Present and Future, Current Molecular Medicine 2021; 21 (10) . https://dx.doi.org/10.2174/1566524021666210121142316
DOI https://dx.doi.org/10.2174/1566524021666210121142316 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Immunomodulatory Effects of Medicinal Plants used for Vitiligo in Traditional Persian Medicine
Current Drug Discovery Technologies Progesterone/Progestagens to Prevent Preterm Birth: When and How
Current Women`s Health Reviews Applications of Animal Models of Infectious Arthritis in Drug Discovery:A focus on Alphaviral Disease
Current Drug Targets Does the Immune System Regulate Mood to Defend against Infection? Evidence from Studies of Immune Factors, Depression, and Antidepressants
Current Psychiatry Reviews A Review on the Synthesis and Chemistry of Bioactive Pyrazolines Bearing 1,2,4-Triazine Moieties
Mini-Reviews in Organic Chemistry Acknowledgements to Contributors:
Recent Patents on Inflammation & Allergy Drug Discovery MicroRNAs in Leukemias: Emerging Diagnostic Tools and Therapeutic Targets
Current Drug Targets The Acute Phase Protein α1-Acid Glycoprotein: A Model for Altered Glycosylation During Diseases
Current Protein & Peptide Science Role of Complement Systems in IVIG Mediated Attenuation of Cognitive Deterioration in Alzheimer's Disease
Current Alzheimer Research Inflammation and Chronic Oxidative Stress in Radiation-Induced Late Normal Tissue Injury: Therapeutic Implications
Current Medicinal Chemistry Dietary Intake and Bone Status with Aging
Current Pharmaceutical Design The Leading Role of Antimicrobial Agents in Modulating the Binomial Host-Microorganism
Current Medicinal Chemistry - Anti-Infective Agents CCR1 Chemokine Receptor Antagonist
Current Pharmaceutical Design Diabetes Mellitus in Saudi Arabia: A Review of the Recent Literature
Current Diabetes Reviews Ecological Infectomics (Ecoinfectomics): Symbiotic Solutions to Microbial Infections
Anti-Infective Agents Fish and Apoptosis: Molecules and Pathways
Current Pharmaceutical Design Cellular Signaling in Cartilage Tissue Engineering
Current Signal Transduction Therapy Role of Probiotics in the Management of Pouchitis
Current Pharmaceutical Design Experimental Approaches Towards Allergic Asthma Therapy-Murine Asthma Models
Recent Patents on Inflammation & Allergy Drug Discovery Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Different Disease States: Recent Updates
Current Medicinal Chemistry